bmi requirements for glp 1 GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis Nearly Four Million Medicare Beneficiaries
Description
Soliqua 100/33 (insulin glargine and lixisenatide injection) [package insert]
Effective integration requires multidisciplinary teams including pediatric endocrinologists, registered dietitians, mental health professionals, and exercise physiologists
However, there are too few relevant studies on the association between GLP-1RA and endometrial cancer to confirm that GLP-1RA can inhibit the proliferation of human endometrial cancer cells, so further research is still needed in the future
This extends the total time to reach the maintenance dose but substantially reduces the likelihood of side effects that cause discontinuation
